Analysis of the clinical characteristics of insulin autoimmune syndrome induced by exogenous insulin in diabetic patients.
Zuojun LiDan YiLijuan ZhengShiran LiWeijin FangChunjiang WangPublished in: Diabetology & metabolic syndrome (2021)
EIAS is an autoimmune disease caused by insulin-binding antibodies in susceptible subjects. Insulin antibodies change glucose dynamics and could increase the incidence of hypoglycemic episodes. Detection of insulin antibodies is the diagnostic test. Changing therapeutic modalities reduced the incidence of hypoglycemic episodes.